These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34725618)

  • 21. Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for England.
    Fraser SD; Aitken G; Taal MW; Mindell JS; Moon G; Day J; O'Donoghue D; Roderick PJ
    PLoS One; 2015; 10(2):e0118676. PubMed ID: 25700182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stronger Association of Albuminuria with the Risk of Vascular Complications than Estimated Glomerular Filtration Rate in Type 2 Diabetes.
    Hong X; Huang L; Zhang Y; Shen X; Weng S; Zeng F; Zhao F; Yan S
    Kidney Blood Press Res; 2021; 46(5):550-562. PubMed ID: 34428770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study.
    Kovesdy CP; Isaman D; Petruski-Ivleva N; Fried L; Blankenburg M; Gay A; Velentgas P; Folkerts K
    Clin Kidney J; 2021 Jun; 14(6):1657-1664. PubMed ID: 34084461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study.
    Koeda Y; Tanaka F; Segawa T; Ohta M; Ohsawa M; Tanno K; Makita S; Ishibashi Y; Itai K; Omama SI; Onoda T; Sakata K; Ogasawara K; Okayama A; Nakamura M
    BMC Nephrol; 2016 May; 17(1):46. PubMed ID: 27169575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Albuminuria, proteinuria, and urinary albumin to protein ratio in chronic kidney disease.
    Wu MT; Lam KK; Lee WC; Hsu KT; Wu CH; Cheng BC; Ng HY; Chi PJ; Lee YT; Lee CT
    J Clin Lab Anal; 2012 Feb; 26(2):82-92. PubMed ID: 22467323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes.
    Rossing P; Groehl F; Mernagh P; Folkerts K; Garreta-Rufas A; Harris J; Meredith K; Carter M; Åkerborg Ö; Wanner C; Hobbs FDR
    J Med Econ; 2023; 26(1):935-943. PubMed ID: 37439218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone.
    Agarwal R; Pitt B; Rossing P; Anker SD; Filippatos G; Ruilope LM; Kovesdy CP; Tuttle K; Vaduganathan M; Wanner C; Bansilal S; Gebel M; Joseph A; Lawatscheck R; Bakris GL
    JAMA Cardiol; 2023 Aug; 8(8):732-741. PubMed ID: 37314801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geographical variation in kidney function testing and associations with health care costs among patients with chronic kidney disease and type 2 diabetes.
    Betts KA; Song J; Elliott J; Warnock N; Farej R; Wu A; Singh R
    Am J Manag Care; 2022 Aug; 28(6 Suppl):S112-S119. PubMed ID: 35997775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial.
    Wexler DJ; de Boer IH; Ghosh A; Younes N; Bebu I; Inzucchi SE; McGill JB; Mudaliar S; Schade D; Steffes MW; Tamborlane WV; Tan MH; Ismail-Beigi F;
    JAMA Intern Med; 2023 Jul; 183(7):705-714. PubMed ID: 37213109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression of Chronic Kidney Disease Risk Categories and Risk of Cardiovascular Disease and Total Mortality: Coronary Artery Risk Development in Young Adults Cohort.
    Choi Y; Jacobs DR; Shroff GR; Kramer H; Chang AR; Duprez DA
    J Am Heart Assoc; 2022 Nov; 11(21):e026685. PubMed ID: 36314497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Kidney Function Measures With Signs of Neurodegeneration and Small Vessel Disease on Brain Magnetic Resonance Imaging: The Atherosclerosis Risk in Communities (ARIC) Study.
    Scheppach JB; Wu A; Gottesman RF; Mosley TH; Arsiwala-Scheppach LT; Knopman DS; Grams ME; Sharrett AR; Coresh J; Koton S
    Am J Kidney Dis; 2023 Mar; 81(3):261-269.e1. PubMed ID: 36179945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 Diabetes.
    Friedman AN; Wang J; Wahed AS; Docherty NG; Fennern E; Pomp A; Purnell JQ; le Roux CW; Wolfe B
    Am J Kidney Dis; 2019 Dec; 74(6):761-770. PubMed ID: 31331758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study.
    Forbes AK; Hinton W; Feher MD; Elson W; Joy M; Ordóñez-Mena JM; Fan X; Cole NI; Banerjee D; Suckling RJ; de Lusignan S; Swift PA
    EClinicalMedicine; 2024 Feb; 68():102426. PubMed ID: 38304744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
    Penno G; Russo E; Garofolo M; Daniele G; Lucchesi D; Giusti L; Sancho Bornez V; Bianchi C; Dardano A; Miccoli R; Del Prato S
    Diabetologia; 2017 Jun; 60(6):1102-1113. PubMed ID: 28357502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and Stratification of Diabetic Kidney Disease Using Serum Cystatin C and Serum Creatinine Based Estimating Equations in Type 2 Diabetes: A Comparative Analysis.
    Avinash S; Singh VP; Agarwal AK; Chatterjee S; Araya V
    J Assoc Physicians India; 2015 Nov; 63(11):28-35. PubMed ID: 29900708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression-real-world clinical practice.
    Aviles Bueno B; Soler MJ; Perez-Belmonte L; Jimenez Millan A; Rivas Ruiz F; Garcia de Lucas MD
    Clin Kidney J; 2022 Aug; 15(8):1593-1600. PubMed ID: 35892023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kidney disease and cognitive function: African American-diabetes heart study MIND.
    Palmer ND; Sink KM; Smith SC; Xu J; Bowden DW; Hugenschmidt CE; Whitlow CT; Williamson JD; Maldjian JA; Divers J; Freedman BI
    Am J Nephrol; 2014; 40(3):200-7. PubMed ID: 25323981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of positive chronic kidney Disease screening in professional male long haul drivers at risk of cardiovascular Disease in Lagos, Nigeria: a cross-section study.
    Amadi CE; Mbakwem AC; Kushimo OA; Ajuluchukwu JN; Akinkunmi M
    BMC Public Health; 2019 Aug; 19(1):1032. PubMed ID: 31370832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.